scispace - formally typeset
T

Thomas A. Down

Researcher at Wellcome Trust/Cancer Research UK Gurdon Institute

Publications -  46
Citations -  16476

Thomas A. Down is an academic researcher from Wellcome Trust/Cancer Research UK Gurdon Institute. The author has contributed to research in topics: DNA methylation & Epigenetics. The author has an hindex of 34, co-authored 46 publications receiving 15651 citations. Previous affiliations of Thomas A. Down include Wellcome Trust Sanger Institute & Novartis Institute for Tropical Diseases.

Papers
More filters
Journal ArticleDOI

NestedMICA: sensitive inference of over-represented motifs in nucleic acid sequence.

TL;DR: This work investigates the performance of NestedMICA in a range scenario, on synthetic data and a well-characterized set of muscle regulatory regions, and compares it with the popular MEME program to show that the new method is significantly more sensitive than MEME.
Journal ArticleDOI

Dalliance: interactive genome viewing on the web

TL;DR: Dalliance is a new genome viewer which offers a high level of interactivity while running within a web browser, making it easy to customize the browser and add extra data.
Journal ArticleDOI

Integrating biological data - the Distributed Annotation System

TL;DR: The various infrastructure components of DAS are described and a new extended version of the DAS specification is presented, which incorporates several recent developments, including its extension to serve new data types and an ontology for protein features.
Journal ArticleDOI

DNA Methylation-mediated Down-regulation of DNA Methyltransferase-1 (DNMT1) Is Coincident with, but Not Essential for, Global Hypomethylation in Human Placenta

TL;DR: Investigation of promoter methylation-mediated epigenetic down-regulation of DNMT genes as a potential regulator of global methylation levels in placental tissue finds specific hypermethylation of the maintenance DNA methyltransferase (DNMT1) gene, which strongly implicates epigenetic regulation of the DNMT gene family in the establishment of the unique epigenetic profile of extraembryonic tissue in humans.